Skip to main content
. 2013 Nov 29;69(4):423–429. doi: 10.1093/gerona/glt192

Table 2.

Association Between Baseline Potentially Inappropriate Medication (PIM) Use and Cognitive Performance (Mean Cognitive Test Scores, by PIM Use)

Unadjusted mean (SE) Adjusted mean (SE)*
Outcome PIM users Nonusers Difference p PIM users Nonusers Difference p
CVLT-II immediate recall (0–36) 22.81 (0.28) 23.62 (0.17) −0.81 (0.33) .02 22.97 (0.27) 23.69 (0.17) −0.72 (0.32) .02
CVLT-II delayed recall (0–9) 4.84 (0.14) 5.22 (0.09) −0.38 (0.16) .02 4.92 (0.14) 5.25 (0.08) −0.33 (0.16) .04
Category fluency 10.07 (0.18) 10.69 (0.11) −0.63 (0.21) .004 10.19 (0.19) 10.72 (0.11) −0.53 (0.22) .01
Verbal fluency 10.54 (0.21) 10.59 (0.13) −0.05 (0.25) .85 10.66 (0.21) 10.61 (0.13) 0.05 (0.25) .84
Trails B 205.4 (8.7) 181.4 (5.2) 24.0 (10.2) .02 188.2 (7.5) 179.7 (4.5) 8.5 (8.8) .33
3MS (transformed) 3.44 (0.07) 3.27 (0.04) 0.17 (0.08) .03 3.33 (0.06) 3.22 (0.04) 0.11 (0.07) .13
Backward digit span (0–14) 5.51 (0.11) 5.47 (0.06) 0.04 (0.12) .72 5.57 (0.10) 5.51 (0.06) 0.06 (0.12) .65

Notes:*adjusted for age, race, education, smoking, physical activity, modified Charlson Comorbidity Index, and baseline Mini Mental State Examination score.

†3MS score was transformed by taking the square root of the number of errors.